Norway· NO-ID_5662C930-0E87-41E0-92DE-37D7C31F570C
Certican
A everolimus product containing everolimus, registered in Norway by Novartis Norge (2). The same ATC class is registered in 9 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Everolimus is registered in 9 of 19 countries.
Countries holding a registration under ATC L04AH02 (everolimus), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 6 of them publish a price we can compare per daily dose
Everolimus · ATC L04AH02
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Switzerlandprice
Price per daily dose
What a daily dose of everolimus costs, country by country.
Normalised to the WHO defined daily dose (1.5 mg), the median price runs from $4.19 in United States to $20.09 in Switzerland — a ×4.8 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Everolimus · price per daily dose (1.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$20.09
- ES Spain$15.84
- US United States$4.19 (acquisition cost)
The record
At a glance
FEST (Norway)- Active substance
- Everolimus
- Manufacturer
- Novartis Norge (2)
- Country
- Norway (NO)
- ATC code
- L04AH02
- ATC class
- Everolimus
- Defined daily dose
- 1.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_5662C930-0E87-41E0-92DE-37D7C31F570C
- no_varenummer01494660NOK 5209.9
- gtin7612797114957
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
428 interactions on record for everolimus.
Graded by severity as the source publishes them — 165 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Everolimus · interactions on record
428 records
- 165 severe
- 255 moderate
- 8 minor
Most severe, free to view
- AprepitantA04AD12severe
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Everolimus in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StateseverolimusAurobindo Pharma Limited
- SpainADEROLIO 1 MG COMPRIMIDOS EFGSandoz Farmaceutica S.A.
- IcelandCerticanNovartis Healthcare A/S
- FinlandAderolioSandoz A/S
- SwedenCertican 1 mg TablettNovartis Sverige AB
- FranceCERTICAN 1,0 mg, compriméNOVARTIS PHARMA
- CzechiaVOTUBIANovartis Europharm Limited, Dublin
- SwitzerlandCertican
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Certican, Everolimus Ethypharm
- Belgium · Certican, Everolimus Eg
- Bulgaria · Еверолимус Крка, Еверолимус Майлан
- Cyprus · Certican, Everolimus Pharmazac
- Czechia · Certican, Everolimus Accord
- Germany · Certican, Everofin
- Denmark · Certican, Everolimus Krka
- Estonia · Certican, Everolimus Krka
- Spain · Certican, Everolimus Accord
- Finland · Aderolio, Certican
- France · Certican, Everolimus Arrow
- United Kingdom (Northern Ireland) · Aderolio, Aderolio 250 Mcg Tablets
- Greece · Certican, Everolimus Faran
- Croatia · Certican, Everolimus Krka
- Hungary · Certican, Everolimus Accord
- Ireland · Certican, Everolimus Tad
- Iceland · Afinitor, Certican
- Italy · Certican, Everolimus Accord
- Liechtenstein · Afinitor, Votubia
- Lithuania · Certican, Everolimus Norameda
- Luxembourg · Certican, Everolimus Eg
- Latvia · Certican, Everolimus Norameda
- Malta · Certican, Everolimus Ascend
- Netherlands · Certican, Certican Dispers
- Poland · Aderolio, Certican
- Portugal · Certican, Everolimus Ethypharm
- Romania · Certican, Everolimus Accord
- Sweden · Certican, Everolimus Avansor
- Slovenia · Certican, Everolimus Krka
- Slovakia · Certican, Everolimus Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1ded5592-dbea-40a7-bd4e-fe480ab9a3c4 GET /v1/drugs/1ded5592-dbea-40a7-bd4e-fe480ab9a3c4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett",
"source": "fest",
"status": "A",
"atc_name": "Everolimus",
"merkevare_id": "ID_5662C930-0E87-41E0-92DE-37D7C31F570C",
"name_form_strength": "Certican tab 1 mg",
"prescription_group": "C"
}See everything about everolimus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.